In this vein, the Genome-Wide-Association-Studies (GWAS) has ascertained that some SNPs (rs2981582, rs1219648, rs2420946, rs2981579) within the FGFR2 intron 2 are associated with an increased breast cancer risk in postmenopausal women [59,60,61]. This evidence concerns the gene FGFR2 and breast carcinoma.